47 completed. 47 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 47 | Completed 47 |
Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Levothyroxine Dosing in Neonatal Congenital Hypothyroidism Levothyroxine - Congenital Hypothyroidism | Phase 4 | Completed | Menoufia University | 101 | 2025-11-02 | 2026-08-10 |
| Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer Ondansetron 8mg, Aprepitant 125 mg - Thyroid Cancer | Phase 4 | Completed | The First Affiliated Hospital of Zhengzhou University | 600 | 2024-07-01 | 2025-01-22 |
| Ropivacaine Plus Magnesium Sulphate Infiltration Placebo Comparator: N/S 0.9%, Ropivacaine 10%, Ropivacaine 10% plus magnesium sulphate 10mg/kg - Thyroid Diseases, Parathyroid Diseases | Phase 4 | Completed | Aristotle University Of Thessaloniki | 68 | 2022-01-19 | 2024-07-17 |
| TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study Teprotumumab, Placebo - Thyroid Eye Disease | Phase 4 | Completed | Amgen | 313 | 2021-09-16 | 2026-08-21 |
| A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease TEPEZZA, Placebo - Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease | Phase 4 | Completed | Amgen | 62 | 2021-09-02 | 2024-07-01 |
| Lidocaine And Neuromonitoring in Thyroid Surgery Intravenous lidocaine, Intravenous placebo, Intra-cuff lidocaine - Thyroid Neoplasm, Parathyroid Neoplasms | Phase 4 | Completed | Saint Petersburg State University, Russia | 110 | 2021-01-25 | 2024-03-21 |
| LIthium as Bridging thErapy Prior to Radioactiveiodine in hyperThYroidism radioactive iodine - Hyperthyroidism/Thyrotoxicosis | Phase 4 | Completed | Universiti Kebangsaan Malaysia Medical Centre | 90 | 2021-01-10 | 2022-08-23 |
| Preoperative Steroids in Autoimmune Thyroid Disease Prednisone - Thyroid Diseases | Phase 4 | Completed | University of Wisconsin, Madison | 30 | 2020-11-13 | 2023-12-26 |
| Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease. Lugols Strong Iodine - Hyperthyroidism, Autoimmune | Phase 4 | Completed | Jesús María Villar del Moral | 184 | 2019-11-25 | 2024-03-06 |
| Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment Indocyanine Green - Thyroid Cancer, Thyroid Goiter | Phase 4 | Completed | University Health Network, Toronto | 10 | 2019-08-06 | 2020-03-27 |
| Hypothyroidism Treated With Calcitonin Calcitonin - Hypothyroidism | Phase 4 | Completed | University of Maryland, Baltimore | 11 | 2018-06-18 | 2022-02-21 |
| A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer Lenvatinib - Thyroid Neoplasms | Phase 4 | Completed | Eisai Pharmaceuticals India Pvt. Ltd | 50 | 2018-04-01 | 2026-03-06 |
| Minimizing Narcotic Analgesics After Endocrine Surgery Acetaminophen 500Mg Cap, Tylenol #3 Oral Tablet, Tramadol - Thyroid Cancer, Thyroid Nodule | Phase 4 | Completed | Minerva A Romero Arenas | 126 | 2018-03-09 | 2021-05-11 |
| 99Tc-MDP for Thyroid-Associated Ophthalmopathy Methylprednisolone, 99Tc-MDP(99Technetium-Methylenediphosphonate Injection) - Thyroid-Associated Ophthalmopathy | Phase 4 | Completed | Dalian University | 50 | 2017-10-16 | 2019-05-15 |
| Thermogenesis in Hyperthyroidism and Effect of Anti-Adrenergic Therapy Propranolol - Hyperthyroidism | Phase 4 | Completed | University Hospital, Basel, Switzerland | 19 | 2017-07-18 | 2020-02-13 |
| Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months MNP group, Placebo group - Iodine Deficiency, Iodine Deficiency Disorder | Phase 4 | Completed | Nutrition Center of the Philippines | 396 | 2014-11-01 | 2015-12-23 |
| Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) Bimatoprost, Eye drop solution - Graves' Ophthalmopathy | Phase 4 | Completed | Cardiff University | 31 | 2014-11-01 | 2016-05-06 |
| Selenium Supplementation in Youths With Autoimmune Thyroiditis L-selenomethionine, Placebo - Autoimmune Thyroiditis | Phase 4 | Completed | Aristotle University Of Thessaloniki | 100 | 2014-08-01 | 2020-02-05 |
| Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism Levothyroxine, Placebo - Thyroid Dysfunction, Mental Fatigue | Phase 4 | Completed | Insel Gruppe AG, University Hospital Bern | 276 | 2014-01-01 | 2019-03-29 |
| Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit Quantitative POC TSH Kit, Qualitative POC TSH Kit, Third generation TSH Kit - Hypothyroidism | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 283 | 2013-10-01 | 2014-11-25 |
Showing 20 of 47. Sign in to see all of them.
Graves Disease (11) · Hypothyroidism (11) · Thyroid Neoplasms (10) · Graves Ophthalmopathy (8) · Hyperthyroidism (4) · Goiter (3) · Thyroid Nodule (3) · Congenital Hypothyroidism (2) · Euthyroid Sick Syndromes (2) · Parathyroid Diseases (2) · Parathyroid Neoplasms (2) · Agnosia (1) · Autoimmune Diseases (1) · Bronchiolitis Obliterans Syndrome (1)
Endocrine System Diseases (47) · Immune System Diseases (18) · Autoimmune Diseases (17) · Orbital Diseases (17) · Exophthalmos (16) · Eye Diseases (16) · Goiter (16) · Hyperthyroidism (16) · Endocrine Gland Neoplasms (11) · Head and Neck Neoplasms (11) · Neoplasms (11) · Neoplasms by Site (11) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10) · Genetic Diseases, Inborn (10)
Thyroxine (9) · Methimazole (4) · Propranolol (3) · Sodium Chloride (3) · Methylprednisolone (2) · Prednisolone (2) · Prednisone (2) · Thyrotropin Alfa (2) · Triiodothyronine (2) · teprotumumab (2) · Acetaminophen (1) · Acetylcysteine (1) · Aprepitant (1) · Bimatoprost (1) · Calcitonin (1)
Amgen (2) · Aristotle University Of Thessaloniki (2) · Copenhagen University Hospital at Herlev (2) · Sanofi (2) · Yonsei University (2) · Cardiff University (1) · Dalian University (1) · Eisai Pharmaceuticals India Pvt. Ltd (1) · Elesta S.R.L. (1) · Federal University of Rio Grande do Sul (1) · Federico II University (1) · GlaxoSmithKline (1) · Göteborg University (1) · Insel Gruppe AG, University Hospital Bern (1) · Jesús María Villar del Moral (1)
United States (9) · China (4) · Denmark (4) · United Kingdom (4) · Germany (3) · India (3) · Italy (3) · South Korea (3) · Greece (2) · Russia (2) · Spain (2) · Sweden (2) · Switzerland (2) · Austria (1) · Brazil (1)
Assimina Galli-Tsinopoulou, Assoc Prof (1) · Birte Nygaard (1) · Birte Nygaard, Md, PhD (1) · Colin M Dayan, MA FRCP PhD (1) · Dawn K Elfenbein (1) · Detao Yin, M.D. (1) · Gabriele Fuchsjaeger-Mayrl, M.D. (1) · Helena Filipsson, Ass Prof (1) · Henry A Reinhart, MD (1) · Hongting Zheng, Ph.D (1)
PMID 10517721, PMID 10683005, PMID 11334386, PMID 11932302, PMID 12656658, PMID 12727961, PMID 12826640, PMID 16837619, PMID 17284630, PMID 17696828, PMID 17711927, PMID 17923793, PMID 18000630, PMID 18366712, PMID 18421188, PMID 18535733, PMID 19138419, PMID 19337012, PMID 19850691, PMID 20039895, PMID 20526530, PMID 20883174, PMID 21175612, PMID 21508145, PMID 21510801, PMID 22356267, PMID 22968823, PMID 23155687, PMID 23158484, PMID 23227861, PMID 23744563, PMID 23844613, PMID 24423358, PMID 25050903, PMID 25148231, PMID 26700485, PMID 27338133, PMID 27432821, PMID 27605368, PMID 27766119, PMID 28460140, PMID 29471876, PMID 29509918, PMID 30165520, PMID 30420883, PMID 32577745, PMID 34195471, PMID 34570185, PMID 36133316, PMID 36743920
2005 (1)